Recombinant erythropoietin in the treatment of anemia in cancer patients

Recombinant erythropoietin in the treatment of anemia in cancer patients

This article reviews the role of recombinant erythropoietin in the management of anemia in cancer patients based on literature data and our experience. We describe the problem of toxicity and report clinical recommendations and cautions for usage of drugs appertain to this pharmaceutical group.

Bibliographic Details
Main Authors:	S. V. Vorobiova, T. Z. Cherniavskaya, S. G. Pushkareva, G. P. Frolov, K. N. Melkova
Format:	Article
Language:	Russian
Published:	ABV-press 2022-11-01
Series:	Онкогематология
Subjects:	anemia erythropoietin r-huepo recommendations complications vero-epoetin
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/684

Similar Items

Epoetin alpha in the treatment of anemia in patients with malignant solid tumors during antitumor drug therapy
by: L. Yu. Vladimirova, et al.
Published: (2022-06-01)

APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
by: O. A. GLADKOV, et al.
Published: (2016-12-01)

Comparative pharmacoeconomic analysis of the use of erythropoiesis-stimulating drugs for the treatment of anemia in cancer patients
by: I. S. Krysanov, et al.
Published: (2021-12-01)

THE ROLE OF ERYTHROPOIETIN IN TREATMENT OF ANEMIA IN CANCER PATIENTS
by: P. G. Berezin, et al.
Published: (2017-06-01)

Erythropoietin levels in geriatric anemia
by: OV Fathima, et al.
Published: (2024-10-01)

Erythropoietin for the treatment of anemia in patients with hematologic disorders
by: R. A. Podgurskaya, et al.
Published: (2022-11-01)

Effect of recombinant human erythropoietin and its combination with tamoxifen on viability of MCF-7 cell in three-dimensional culture
by: Shujaaedin, Hareth Yahya Ahmed
Published: (2019)

RATIONAL SUPPORTIVE THERAPY FOR CHEMOTHERAPY INDUCED ANEMIA: A PHARMACO-ECONOMIC ANALYSIS OF ERYTHROPOIETIN THERAPY IN CANCER PATIENTS IN RUSSIAN FEDERATION
by: V. B. Larionova, et al.
Published: (2018-07-01)

CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS
by: V. D. Nazarov, et al.
Published: (2018-01-01)

The Role of Erythropoietin in Preventing Anemia in the Premature Neonate
by: Oana Cristina Costescu, et al.
Published: (2023-11-01)

Serum Erythropoietin Levels in Pediatric Hematologic Disorders and Impact of Recombinant Human Erythropoietin Use
by: Mualla Çetin, et al.
Published: (2009-06-01)

HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Sofia Omari, et al.
Published: (2011-05-01)

HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Alhossain A. Khalafallah, et al.
Published: (2011-01-01)

Experience with luspatercept therapy in patients with transfusion-dependent low-risk myelodysplastic syndromes in real-world clinical practice: exploring the positive effect of combination with erythropoietin alfa
by: Anna Jonasova, et al.
Published: (2024-10-01)

Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
by: Xiaomeng Zheng, et al.
Published: (2023-12-01)

Potency evaluation of erythropoietin products: current status
by: L. A. Gaiderova, et al.
Published: (2024-12-01)

A Single Arm Clinical Study on the Effects of Continuous Erythropoietin Receptor Activator Treatment in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia
by: Akira Sezai, et al.
Published: (2023-03-01)

Pegmolesatide for the treatment of anemia in patients undergoing dialysis: a randomized clinical trialResearch in context
by: Ping Zhang, et al.
Published: (2023-11-01)

The role of erythropoietins in cancer therapy
by: O. E. Kondratieva, et al.
Published: (2018-07-01)

Chitosan and Hyaluronic Acid Nanoparticles as Vehicles of Epoetin Beta for Subconjunctival Ocular Delivery
by: Beatriz Silva, et al.
Published: (2022-02-01)

Erythropoietin in Cardiorenal Anemia Syndrome
by: Emir Fazlibegović, et al.
Published: (2008-11-01)

The use of epoetin alfa biosimilar in the anemia management in hemodialysis patients
by: I. O. Dudar, et al.
Published: (2021-02-01)

Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study
by: Hiroaki Io, et al.
Published: (2023-03-01)

Impact of erythropoietin on anemia in end-stage renal disease patients on hemodialysis
by: Bashaer M Muhammad-Baqir, et al.
Published: (2023-01-01)

Association Between the Polymorphism of Angiotensin-Converting Enzyme Gene and Interleukin-1 Beta Gene and the Response to Erythropoietin Therapy in Dialysis Patients with Anemia
by: Dzekova-Vidimliski P, et al.
Published: (2024-03-01)

Evaluation of Erythropoietin Stimulating Agent’s Responsiveness and Associated Factors in Hemodialysis Patients with Anemia
by: Salar Ahmed Alzubaidy, et al.
Published: (2024-09-01)

Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open‐label, parallel‐group, noninferiority phase III trial
by: Bicheng Liu, et al.
Published: (2022-06-01)

Association of Erythropoietin, Adiponectin and Leptin levels with Anemia in uremic diabetic patients (Under hemodialysis):
by: Salim M. Al-Rubaâe, et al.
Published: (2011-01-01)

Lipocalin-2, Soluble Transferrin Receptor, and Erythropoietin in Anemia During Mild Renal Dysfunction
by: Nahm CH, et al.
Published: (2023-08-01)

Erythropoietin: A Personal Alice in Wonderland Trip in the Shadow of the Giants
by: Anna Rita Migliaccio
Published: (2024-03-01)

Early administration of erythropoietin in extremely very low birth weight preterms
by: Mihaela Demetrian, et al.
Published: (2019-09-01)

EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY
by: V. M. Provotorov, et al.
Published: (2016-01-01)

Serum erythropoietin level in anemic and non-anemic patients with chronic leukemia
by: Ali Hasan Allami Hussein, et al.
Published: (2023-01-01)

The Frequency of Resistance to Synthetic Erythropoietin and Its Risk Factors among Chronic Hemodialysis Patients in Kerman
by: Abbas Etminan, et al.
Published: (2018-01-01)

Intravenous iron and erythropoietin therapy for postoperative anemia among orthopedic surgery patients
by: Huixin Chen, et al.
Published: (2023-07-01)

Gamma-Aminobutyric Acid Increases Erythropoietin by Activation of Citrate Cycle and Stimulation of Hypoxia-Inducible Factors Expression in Rats
by: Keun-Tae Park, et al.
Published: (2020-04-01)

SELECTION OF THERAPEUTIC TACTICS FOR EARLY ANEMIA OF PREMATURE INFANTS WITH VERY LOW OR EXTREMELY LOW BIRTH WEIGHT: RETROSPECTIVE STUDY RESULTS
by: O. A. Senkevich, et al.
Published: (2016-02-01)

Characteristics of erythropoietin antibodies in patients treated with recombinant human erythropoietin
by: A. M. Kudryashova, et al.
Published: (2020-01-01)

Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
by: N. A. Romanenko
Published: (2014-07-01)

The resistance to methoxy polyethylene glycol-epoetin beta in anemic patients of end-stage renal disease
by: Sattar J. Abood, et al.
Published: (2023-02-01)